What happened in this episode?
ZOE host Jonathan Wolf interviews Professor Ela Dennison of the University of Southampton about bone biology, osteoporosis and fracture risk. Dennison describes bone as living tissue in constant turnover, with osteoclasts breaking down micro-damage and osteoblasts rebuilding it; she says people typically build towards peak bone mass until about age 30 before gradual decline, accelerated in many women after menopause due to oestrogen withdrawal.
She outlines who is at higher risk of osteoporosis, including older adults, people on long-term steroid tablets, those with a history of anorexia, and people with gastrointestinal diseases that impair nutrient absorption. Dennison argues the main public consequence of low bone density is fragility fracture, and describes severe outcomes after hip fracture, including a substantial early mortality risk.
The discussion covers screening and risk tools (DEXA scans and the FRAX questionnaire), medication options (anti-resorptives such as bisphosphonates and denosumab, plus bone-forming therapies including PTH injections and romosozumab), and lifestyle measures. Dennison recommends weight-bearing and resistance exercise, adequate dietary calcium and vitamin D, and highlights the Mediterranean diet as the most consistently studied pattern associated with better bone health. She also discusses smoking, alcohol, stress and cortisol, and flags open questions about whether GLP-1 weight-loss drugs could affect long-term fracture risk via muscle loss. The episode includes a mid-show promotion for ZOE’s “Daily 30” supplement.